ACG 2021 Annual Scientific Meeting & Postgraduate Course Oct 2021

This year the annual ACG meeting is back after its one year hiatus due to COVID-19. Below are my recommendations for must attend events. I hope to see everyone attending at the Berk Lecture. Dr. Sayuk, (last but not least) has a fascinating lecture planed on Acute Heptic Porphyria (AHP) on Tuesday (26 October 2021). There will be much discussion on COVID-19 and its impact on GI practices world wide. With the public “overly alert” to the signs and symptoms of COVID-19 and its variants, self misdiagnosis can be problematic when the layman blames symptoms on COVID, waits days for test results, only to test negative and then need urgent care as systems persist.

Sunday, October 24

Knowledge Is Power

Miguel D. Regueiro, MD, FACG
5:15 pm – 6:00 pm
An interactive discussion of Crohn’s disease data led by IBD expert Miguel Regueiro.
This program is sponsored by AbbVie.

A New Once-Daily Oral Treatment Option for Your Adult Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Stephen B. Hanauer, MD, MACG
6:15 pm – 7:00 pm
Please join us for a presentation on the first and only sphingosine 1-phosphate (S1P) receptor modulator approved for the treatment of moderately to severely active UC in adults. In this program, Dr. Hanauer will provide an overview of the role of S1P signaling in UC, as well as the efficacy and safety data for ozanimod.

This program is sponsored by Bristol Myers Squibb.

Monday, October 25

Rethinking First-line Treatment of Helicobacter pylori

Neil H. Stollman, MD, FACG
12:45 pm – 1:20 pm
It is a promotional program sponsored by RedHill that is designed to educate and inform HCPs and/or Patients about the benefits, risks, and appropriate uses of Talicia, as well as topics that support the day-to-day care of Patients. It will provide information on Talicia, H. pylori for which the product is indicated.
This program is sponsored by RedHill Biopharma.

Discuss the diagnosis of Exocrine Pancreatic Insufficiency (EPI) and the treatment with CREON.

Nathaniel Ranney, MD
1:40 pm – 2:15 pm
Discuss the diagnosis of Exocrine Pancreatic Insufficiency (EPI) and the treatment with CREON.
This program is sponsored by AbbVie.

Understanding Acute Hepatic Porphyria (AHP): Unexplained, recurrent abdominal pain

Tuesday, October 26

Gregory S. Sayuk, MD, MPH
1:40 pm – 2:15 pm
Please join Dr. Greg Sayuk as he utilizes a case-based approach to provide an overview of acute hepatic porphyria (AHP), explore the long, often unpredictable patient journey with AHP, and highlight the importance of the gastroenterologist’s role in recognizing and testing for AHP. AHP is characterized by debilitating, potentially life-threatening attacks, of which the cardinal symptom is severe, diffuse abdominal pain, along with one or more other unexplained symptoms, which may include nausea or vomiting, psychological symptoms (anxiety or confusion), tachycardia, hypertension, and limb weakness or pain.
This program is sponsored by Alnylam Pharmaceuticals